Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Oncocyte Corp (OCX)

Oncocyte Corp (OCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Oncocyte Corporation to Present at the LD Micro Invitational XIII

Irvine, California--(Newsfile Corp. - June 1, 2023) - Oncocyte Corporation (NASDAQ: OCX) announced today that it will be presenting at the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard...

OCX : 2.98 (-0.60%)
Elevance Health (ELV) Tops Q1 Earnings and Revenue Estimates

Elevance Health (ELV) delivered earnings and revenue surprises of 2.16% and 2.48%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ELV : 519.96 (+0.53%)
OCX : 2.98 (-0.60%)
3 Medical Services Stocks to Buy Amid Industry Challenges

The Zacks Medical - Services industry is growing on digital healthcare adoption. EMBC, INNV and OCX are set to gain the most. However, staffing shortages may disrupt the trend.

EMBC : 12.90 (+4.45%)
OCX : 2.98 (-0.60%)
INNV : 4.34 (+2.36%)
Life Time Group Holdings, Inc. (LTH) Tops Q4 Earnings and Revenue Estimates

Life Time Group Holdings, Inc. (LTH) delivered earnings and revenue surprises of 16.67% and 0.03%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

LTH : 15.41 (+4.69%)
OCX : 2.98 (-0.60%)
Viatris (VTRS) Matches Q4 Earnings Estimates

Viatris (VTRS) delivered earnings and revenue surprises of 0% and 2.32%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

VTRS : 11.83 (+1.98%)
OCX : 2.98 (-0.60%)
OncoCyte (OCX) Upgraded to Buy: What Does It Mean for the Stock?

OncoCyte (OCX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

OCX : 2.98 (-0.60%)
OncoCyte (OCX) Reports Q3 Loss, Misses Revenue Estimates

OncoCyte (OCX) delivered earnings and revenue surprises of 38.46% and 32.20%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

OCX : 2.98 (-0.60%)
IMCC : 0.4112 (-9.75%)
OncoCyte (OCX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

After losing some value lately, a hammer chart pattern has been formed for OncoCyte (OCX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions,...

OCX : 2.98 (-0.60%)
Strength Seen in Cano Health, Inc. (CANO): Can Its 32.2% Jump Turn into More Strength?

Cano Health, Inc. (CANO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase...

CANO : 2.30 (-2.13%)
OCX : 2.98 (-0.60%)
Here's Why OncoCyte (OCX) Looks Ripe for Bottom Fishing

OncoCyte (OCX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street...

OCX : 2.98 (-0.60%)

Barchart Exclusives

This VIX Butterfly Spread has a 15 to 1 Reward to Risk Ratio
Market volatility remains subdued as measured by the CBOE Volatility (VIX) Index. VIX is a real-time index that represents the market expectation for near-term volatility in the S&P 500 index. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar